Vetter introduces Vetter-Ject®, a closure system for prefilled syringes. The closure allows for a baked-in siliconization of an integrated needle syringe, making it suitable for highly sensitive compounds such as biologics. The tamper-evident closure system, combined with an integrated staked needle, supports the product’s integrity.
Pharmaceutical and biotech companies are developing drugs that incorporate sensitive and complex compounds. To best administer these drugs patients require an injection system that offers flexibly while being safe and simple to handle. Consisting of a needle hub and a needle shield, the new syringe closure system is partly produced by means of a two-component injection molding process using polypropylene and thermoplastic elastomer.
Due to the baked-in siliconization process for the glass barrel, less silicon is necessary, making Vetter-Ject particularly suitable for silicon-sensitive drug products. The silicon content of the syringe can also be adjusted according to customer requirements. Thus, the amount of silicon used, as well as the related particle load, can be reduced by up to 80% when compared to the standard siliconization process applied to conventional syringe systems.
